Luis Diaz, co-founder of PGDx, said the new funding will allow the company to "go out and sell" the cancer diagnostics tech it has been working on for a decade.
Image: Baltimore's Personal Genome Diagnostics (PGDx) has raised about $214 million in funding to date. CARLEY MILLIGAN